
The U.S.’s long winter of airborne virus spread continues. COVID-19 is still spreading at higher levels in some parts of the country, particularly in the Midwest, and may be increasing further in other regions. Flu remains at high levels, too, as the influenza B strain continues to rise.

Op-eds, sometimes known as opinion or commentary, have been powerful in raising awareness and providing solutions for Long COVID, from early reports of the disease to calls to action that have inspired legislation.

Both COVID-19 and the seasonal flu have been spreading at higher levels in the U.S. for months now, and that trend is likely to continue with both pathogens for several more weeks. While national COVID-19 metrics are stable or slowly declining, the disease is increasing in concentration in some parts of the country as it…

The U.S.’s long winter COVID-19 wave continues. Major national metrics are at plateaus as of late January, as disease levels increase in some regions and decrease in others. In better news, flu levels are declining again, after an uptick last week.

Maryland may soon become the first U.S. state to directly support Long COVID research and development. The state’s government is considering a bill that would establish a grant and loan program dedicated to the disease, potentially funding scientists and start-ups based in Maryland.

COVID-19 levels are going up in parts of the South, West, and possibly the Midwest, while continuing to decline elsewhere. Trends suggest we may be in for a second round of this winter’s COVID-19 wave after the initial peak in early January. Flu levels increased this week, too, likely due to more influenza B spread.

Several national COVID-19 metrics have now reported two weeks of declines, suggesting we have passed the peak of this winter’s wave — but higher disease levels may continue for many more weeks.

The RECOVER-Treating Long COVID initiative is set to begin enrolling participants in new clinical trials this summer, which will mark nearly two years after the National of Institutes of Health (NIH) effort launched with promises to deliver greater urgency for this chronic disease impacting tens of millions of Americans.

The COVID-19 trends surprised me this week: several major national metrics are trending down, despite not yet reaching high levels comparable to what we typically see at the peaks of surges. This could be good news, but tread with caution; these data are preliminary, and SARS-CoV-2 is an unpredictable virus.

Our record-high flu season may have peaked in the U.S. as of early January, but levels of that disease remain very high while COVID-19 rates continue to increase across most of the country. This winter is shaping up to be a long one for airborne virus spread.
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance